8-K: McKesson Affirms Fiscal 2025 Earnings Guidance at Wells Fargo Healthcare Conference

McKesson Corporation reaffirmed its full-year fiscal 2025 adjusted earnings per diluted share guidance and provided second-quarter fiscal 2025 earnings expectations during a presentation at the Wells Fargo 2024 Healthcare Conference.

Summary

• McKesson Corporation participated in the Wells Fargo 2024 Healthcare Conference on September 5, 2024.
• The company reaffirmed its fiscal year 2025 adjusted earnings per diluted share guidance to be between $31.75 and $32.55.
• McKesson anticipates second quarter fiscal 2025 adjusted earnings per diluted share to be in the range of $6.70 to $7.00.
• The company defines adjusted earnings per diluted share as GAAP earnings excluding certain items such as amortization of acquisition-related intangibles, transaction-related expenses, LIFO adjustments, and other non-recurring items.
• McKesson does not provide forward-looking guidance on a GAAP basis due to the difficulty in forecasting certain non-GAAP adjustments.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as the company reaffirmed its full-year guidance and provided second-quarter expectations, indicating stability and predictability. However, the document also includes a long list of risk factors, which tempers the overall positive sentiment.

Positives

• The reaffirmation of the full-year earnings guidance provides stability and predictability for investors.
• The provided second-quarter earnings guidance gives investors a near-term outlook on the company's performance.

Risks

• The company faces risks related to legal disputes, including those related to opioid distribution.
• McKesson could experience losses not covered by insurance or indemnification.
• The company is subject to complex and changing healthcare laws.
• Impairment charges to goodwill and other assets could negatively impact financial results.
• Cybersecurity incidents and data breaches pose a risk to the company's operations.
• The company may not achieve its strategic growth objectives or cost reduction initiatives.
• Customer purchase reductions, contract non-renewals, and bankruptcies could impact revenue.
• Changes in relationships with suppliers could negatively affect the business.
• Healthcare reform and industry consolidation could pose challenges.
• Disruptions in product supply and changes in economic environments could impact the company.
• Changes in capital markets could affect access to credit and increase borrowing costs.
• Tax legislation changes and challenges to tax positions could impact the company.
• Events outside of the company's control, such as public health issues and natural disasters, could have an adverse effect.
• Global climate change and related responses could impact the business.
• Governance issues and regulations related to social issues, climate change, and sustainability could have an adverse effect.

Future Outlook

McKesson has provided full-year fiscal 2025 adjusted earnings per diluted share guidance and second-quarter fiscal 2025 adjusted earnings per diluted share expectations.

Management Comments

• McKesson affirmed fiscal 2025 full year Adjusted Earnings per Diluted Share guidance in the range of $31.75 to $32.55.
• McKesson also indicated it anticipates second quarter fiscal 2025 Adjusted earnings per Diluted Share to be in the range of $6.70 to $7.00.

Industry Context

This announcement is consistent with the typical practice of companies providing earnings guidance and updates at industry conferences, allowing investors to gauge the company's performance relative to expectations.

Comparison to Industry Standards

• McKesson's practice of providing adjusted earnings guidance is common among large healthcare companies, as it helps investors understand the underlying profitability of the business by excluding non-recurring items.
• Comparable companies like Cardinal Health and AmerisourceBergen also provide similar non-GAAP guidance to investors.
• The provided guidance is in line with the expectations of analysts who follow the healthcare distribution sector.

Stakeholder Impact

• Shareholders will be impacted by the reaffirmed earnings guidance and second-quarter expectations.
• Employees may be impacted by the company's performance and strategic initiatives.
• Customers and suppliers may be impacted by changes in the company's operations and relationships.

Key Dates

Keywords

Earnings Guidance, Adjusted Earnings Per Share, Healthcare Conference, Financial Outlook, McKesson, Non-GAAP Measures